Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin.2001;51:15-36.
Winawer SJ, Fletcher RH, Miller L.
et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology.1997;112:594-642.
United States Preventive Services Task Force. Clinical guidelines: screening for colorectal cancer: recommendation
and rationale. Ann Intern Med.2002;137:129-131.
Rex DK, Johnson DA, Lieberman DA, Burt DW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the
American College of Gastroenterology. Am J Gastroenterol.2000;95:868-877.
Smith RA, von Eschernbach AC, Wender R.
et al. American Cancer Society guidelines for the early detection of cancer:
update of early detection guidelines for prostate, colorectal, and endometrial
cancers; also update 2000—testing for early lung cancer detection. CA Cancer J Clin.2001;51:38-75, quiz, 77-80.
Morson B. President's address: the polyp-cancer sequence in the large bowel. Proc R Soc Med.1974;67:451-457.
Morson BC. The evolution of colorectal carcinoma. Clin Radiol.1984;35:425-431.
Bond JH. Clinical evidence for the adenoma-carcinoma sequence, and the management
of patients with colorectal adenomas. Semin Gastrointest Dis.2000;11:176-184.
Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients
with colorectal polyps: Practice Parameters Committee of the American College
of Gastroenterology. Am J Gastroenterol.2000;95:3053-3063.
Rembacken BJ, Fujii T, Cairns A.
et al. Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies
in the UK. Lancet.2000;355:1211-1214.
Saitoh Y, Waxman I, West AB.
et al. Prevalence and distinctive biologic features of flat colorectal adenomas
in a North American population. Gastroenterology.2001;120:1657-1665.
Mandel JS, Bond JH, Church TR.
et al. Reducing mortality from colorectal cancer by screening for fecal occult
blood: Minnesota Colon Cancer Control Study. N Engl J Med.1993;328:1365-1371.
Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for
fecal occult blood. J Natl Cancer Inst.1999;91:434-437.
Hardcastle JD, Chamberlain JO, Robinson MH.
et al. Randomised controlled trial of faecal-occult-blood screening for colorectal
Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occult blood screening on mortality from colorectal
cancer: results from a randomised controlled trial. Gut.2002;50:840-844.
Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood
Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal
occult blood testing: results after 13 years and seven biennial screening
Mandel JS, Church TR, Bond JH.
et al. The effect of fecal occult-blood screening on the incidence of colorectal
cancer. N Engl J Med.2000;343:1603-1607.
Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med.1996;334:155-159.
Young GP, St John DJ, Winawer SJ, Rozen P. Choice of fecal occult blood tests for colorectal cancer screening:
recommendations based on performance characteristics in population studies:
a WHO (World Health Organization) and OMED (World Organization for Digestive
Endoscopy) report. Am J Gastroenterol.2002;97:2499-2507.
Pignone M, Campbell MK, Carr C, Phillips C. Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract.2001;4:150-156.
Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer: is mortality reduced
by chance selection for screening colonoscopy? JAMA.1994;271:1011-1013.
Church TR, Ederer F, Mandel JS. Fecal occult blood screening in the Minnesota study: sensitivity of
the screening test. J Natl Cancer Inst.1997;89:1440-1448.
Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a
background paper: American College of Physicians. Ann Intern Med.1997;126:811-822.
Winawer SJ, Fletcher RH, Miller L.
et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology.1997;112:594-642.
Anderson ML, Pasha TM, Leighton JA. Endoscopic perforation of the colon: lessons for a 10-year study. Am J Gastroenterol.2000;95:3418-3422.
Zubarik R, Fleischer DE, Mastropietro C.
et al. Prospective analysis of complications 30 days after outpatient colonoscopy. Gastrointest Endosc.1999;50:322-328.
American College of Physicians. Suggested technique for fecal occult blood testing and interpretation
in colorectal cancer screening. Ann Intern Med.1997;126:808-810.
Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasm: sensitivity,
specificity, and predictive value: long-term follow-up in a large group practice
setting. Ann Intern Med.1990;112:328-333.
Ahlquist DA, Wieand HS, Moertel CG.
et al. Accuracy of fecal occult blood screening for colorectal neoplasia:
a prospective study using Hemoccult and HemoQuant tests. JAMA.1993;269:1262-1267.
Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood
testing and examination of the distal colon. N Engl J Med.2001;345:555-560.
Prorok PC, Andriole GL, Bresalier RS.
et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer
screening trial. Control Clin Trials.2000;21(6 suppl):273S-309S.
Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet.1993;341:736-740.
Atkin WS, Hart A, Edwards R.
et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy
UK Flexible Sigmoidoscopy Screening Trials Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer:
baseline findings of a UK multicentre randomised trial. Lancet.2002;359:1291-1300.
Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population-based surveillance by colonoscopy: effect on the incidence
of colorectal cancer: Telemark Polyp Study I. Scand J Gastroenterol.1999;34:414-420.
Hoff G, Thiis-Evensen E, Grotmol T, Sauar J, Vatn MH, Moen IE. Do undesirable effects of screening affect all-cause mortality in flexible
sigmoidoscopy programmes? experience from the Telemark Polyp Study 1983-1996. Eur J Cancer Prev.2001;10:131-137.
Selby JV, Friedman GD, Quesenberry Jr CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from
colorectal cancer. N Engl J Med.1992;326:653-657.
Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst.1992;84:1572-1575.
Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy:
a case-control study of 32,702 veterans. Ann Intern Med.1995;123:904-910.
Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer: a case-control
study among veterans. Arch Intern Med.1995;155:1741-1748.
Kavanagh AM, Giovannucci EL, Fuchs CS, Colditz GA. Screening endoscopy and risk of colorectal cancer in United States
men. Cancer Causes Control.1998;9:455-462.
Rex DK, Lehman GA, Hawes RH, O'Connor KW, Smith JJ. Performing screening flexible sigmoidoscopy using colonoscopes: experience
in 500 subjects. Gastrointest Endosc.1990;36:486-488.
Schertz RD, Baskin WN, Frakes JT. Flexible fiberoptic sigmoidoscopy training for primary care physicians:
results of a 5-year experience. Gastrointest Endosc.1989;35:316-320.
Cash BD, Schoenfeld PS, Ransohoff DF. Licensure, use, and training of paramedical personnel to perform screening
flexible sigmoidoscopy. Gastrointest Endosc.1999;49:163-169.
American Society for Gastrointestinal Endoscopy. Guidelines for training non-specialists in screening flexible sigmoidoscopy. Gastrointest Endosc.2000;51:783-785.
Wallace MB, Kemp JA, Meyer F.
et al. Screening for colorectal cancer with flexible sigmoidoscopy by nonphysician
endoscopists. Am J Med.1999;107:214-218.
Schoenfeld P, Lipscomb S, Crook J.
et al. Accuracy of polyp detection by gastroenterologists and nurse endoscopists
during flexible sigmoidoscopy: a randomized trial. Gastroenterology.1999;117:312-318.
Levin TR, Conell C, Shapiro JA, Chazan SG, Nadel M, Selby JV. Complications of screening sigmoidoscopy. Gastroenterology.2002;123:1786-1792.
Atkin WS, Edwards R, Wardle J, Northover JM, Cuzick J. UK flexible sigmoidoscopy screening trial: compliance, yield and adverse
events [abstract]. Gastroenterology.2000;118:A187.
Zarchy TM, Ershoff D. Do characteristics of adenomas on flexible sigmoidoscopy predict advanced
lesions on baseline colonoscopy? Gastroenterology.1994;106:1501-1504.
Read TE, Read JD, Butterly LF. Importance of adenomas 5 mm or less in diameter that are detected by
sigmoidoscopy. N Engl J Med.1997;336:8-12.
Schoen RE, Corle D, Cranston L.
et al. Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy?
the Polyp Prevention Trial. Gastroenterology.1998;115:533-541.
Wallace MB, Kemp JA, Trnka YM, Donovan JM, Farraye FA. Is colonoscopy indicated for small adenomas found by screening flexible
sigmoidoscopy? Ann Intern Med.1998;129:273-278.
Levin TR, Palitz A, Grossman S.
et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA.1999;281:1611-1617.
Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according
to the distal colorectal findings. N Engl J Med.2000;343:169-174.
Rex DK, Lehman GA, Ulbright TM, Smith JJ, Hawes RH. The yield of a second screening flexible sigmoidoscopy in average-risk
persons after one negative examination. Gastroenterology.1994;106:593-595.
Schoen RE, Wissfeld J, Bresalier R.
et al. The yield of repeat flexible sigmoidoscopy three years after a negative
exam: results from the PLCO cancer screening trial [abstract]. Gastroenterology.2002;122:A355.
Lemmel GT, Haseman JH, Rex DK, Rahmani E. Neoplasia distal to the splenic flexure in patients with proximal colon
cancer. Gastrointest Endosc.1996;44:109-111.
Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer:
Veterans Affairs Cooperative Study 380. N Engl J Med.2000;343:162-168.
Winawer SJ, Zauber AG, Church T.
et al. National colonoscopy study preliminary results: a controlled trial
of general population screening colonoscopy. Gastroenterology.2002;122:T1560.
Winawer SJ, Zauber AG, Ho MN.
et al. Prevention of colorectal cancer by colonoscopic polypectomy: the National
Polyp Study Workgroup. N Engl J Med.1993;329:1977-1981.
Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M. Efficacy in standard clinical practice of colonoscopic polypectomy
in reducing colorectal cancer incidence. Gut.2001;48:812-815.
Marshall JB. Technical proficiency of trainees performing colonoscopy: a learning
curve. Gastrointest Endosc.1995;42:287-291.
Nelson DB, McQuaid KR, Bond JH, Lieberman DA, Weiss DG, Johnston TK. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc.2002;55:307-314.
Winawer SJ, Zauber AG, O'Brien MJ.
et al. Randomized comparison of surveillance intervals after colonoscopic
removal of newly diagnosed adenomatous polyps: the National Polyp Study Workgroup. N Engl J Med.1993;328:901-906.
Zauber AG, Winawer SJ, Bond JH.
et al. Can surveillance intervals be lengthened following colonoscopic polypectomy
Rex DK, Cummings OW, Helper DJ.
et al. 5-year incidence of adenomas after negative colonoscopy in asymptomatic
average-risk persons [see comment]. Gastroenterology.1996;111:1178-1181.
Avidan B, Sonnenberg A, Schnell TG, Leya J, Metz A, Sontag SJ. New occurrence and recurrence of neoplasms within 5 years of a screening
colonoscopy. Am J Gastroenterol.2002;97:1524-1529.
Hixson LJ, Fennerty MB, Sampliner RE, Garewal HS. Prospective blinded trial of the colonoscopic miss-rate of large colorectal
polyps. Gastrointest Endosc.1991;37:125-127.
Rex DK, Cutler CS, Lemmel GT.
et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology.1997;112:24-28.
Bensen S, Mott LA, Dain B, Rothstein R, Baron J. The colonoscopic miss rate and true one-year recurrence of colorectal
neoplastic polyps: Polyp Prevention Study Group. Am J Gastroenterol.1999;94:194-199.
Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and
sigmoidoscopy. J Natl Cancer Inst.1993;85:1311-1318.
Berry DP, Clarke P, Hardcastle JD, Vellacott KD. Randomized trial of the addition of flexible sigmoidoscopy to faecal
occult blood testing for colorectal neoplasia population screening. Br J Surg.1997;84:1274-1276.
Rasmussen M, Kronborg O, Fenger C, Jorgensen OD. Possible advantages and drawbacks of adding flexible sigmoidoscopy
to hemoccult-II in screening for colorectal cancer: a randomized study. Scand J Gastroenterol.1999;34:73-78.
Verne JE, Aubrey R, Love SB, Talbot IC, Northover JM. Population based randomized study of uptake and yield of screening
by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ.1998;317:182-185.
Levin TR, Allison JE, Sakoda L.
et al. Adding new fecal occult blood tests to sigmoidoscopy: what is the added
yield [abstract]. Gastroenterology.2000;118:A441.
Kim LS, Koch J, Yee J, Halvorsen R, Cello JP, Rockey DC. Comparison of patients' experience during imaging tests of the colon. Gastrointest Endosc.2001;54:67-74.
Kewenter J, Brevinge H. Endoscopic and surgical complications of work-up in screening for colorectal
cancer. Dis Colon Rectum.1996;39:676-680.
Blakeborough A, Sheridan MB, Chapman AH. Complications of barium enema examinations: a survey of UK Consultant
Radiologists 1992 to 1994. Clin Radiol.1997;52:142-148.
Johnson CD, Ilstrup DM, Fish NM.
et al. Barium enema: detection of colonic lesions in a community population. AJR Am J Roentgenol.1996;167:39-43.
Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS. Relative sensitivity of colonoscopy and barium enema for detection
of colorectal cancer in clinical practice. Gastroenterology.1997;112:17-23.
Law RL, Longstaff AJ, Slack N. A retrospective 5-year study on the accuracy of the barium enema examination
performed by radiographers. Clin Radiol.1999;54:80-83; discussion 83-84.
Strom E, Larsen JL. Colon cancer at barium enema examination and colonoscopy: a study from
the county of Hordaland, Norway. Radiology.1999;211:211-214.
Winawer SJ, Stewart ET, Zauber AG.
et al. A comparison of colonoscopy and double-contrast barium enema for surveillance
after polypectomy: National Polyp Study Work Group. N Engl J Med.2000;342:1766-1772.
Hara AK, Johnson CD, Reed JE.
et al. Detection of colorectal polyps with CT colonography: initial assessment
of sensitivity and specificity. Radiology.1997;205:59-65.
Rex DK, Vining D, Kopecky KK. An initial experience with screening for colon polyps using spiral
CT with and without CT colonography (virtual colonoscopy). Gastrointest Endosc.1999;50:309-313.
Fenlon HM, Nunes DP, Schroy 3rd PC, Barish MA, Clarke PD, Ferrucci JT. A comparison of virtual and conventional colonoscopy for the detection
of colorectal polyps. N Engl J Med.1999;341:1496-1503.
Fletcher JG, Johnson CD, Welch TJ.
et al. Optimization of CT colonography technique: prospective trial in 180
Hara AK, Johnson CD, Welch TJ, McCollough CH, Harmsen WS. CT colonography: single versus multi-detector row imaging. Radiology.2001;219:461-465.
Yee J, Akerkar GA, Hung RK, Steinauer-Gebauer AM, Wall SD, McQuaid KR. Colorectal neoplasia: performance characteristics of CT colonography
for detection in 300 patients. Radiology.2001;219:685-692.
Cotton PB, Durkalski VL, Palesch YY.
et al. Comparison of virtual colonoscopy and colonoscopy in the detection
of polyps/masses [abstract]. Gastrointest Endosc.2002;55:A594.
Pescatore P, Glucker T, Delarive J.
et al. Diagnostic accuracy and interobserver agreement of CT colonography
(virtual colonoscopy). Gut.2000;47:126-130.
Miao YM, Amin Z, Healy J.
et al. A prospective single centre study comparing computed tomography pneumocolon
against colonoscopy in the detection of colorectal neoplasms. Gut.2000;47:832-837.
Spinzi G, Belloni G, Martegani A, Sangiovanni A, Del Favero C, Minoli G. Computed tomographic colonography and conventional colonoscopy for
colon diseases: a prospective, blinded study. Am J Gastroenterol.2001;96:394-400.
Zalis ME, Hahn PF. Digital subtraction bowel cleansing in CT colonography. AJR Am J Roentgenol.2001;176:646-648.
Bond JH. Virtual colonoscopy—promising, but not ready for widespread use. N Engl J Med.1999;341:1540-1542.
Akerkar GA, Yee J, Hung R, McQuaid K. Patient experience and preferences toward colon cancer screening: a
comparison of virtual colonoscopy and conventional colonoscopy. Gastrointest Endosc.2001;54:310-315.
Sonnenberg A, Delco F, Bauerfiend P. Is virtual colonoscopy a cost-effective option to screen for colorectal
cancer? Am J Gastroenterol.1999;94:2268-2274.
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell.1990;61:759-767.
Sidransky D, Tokino T, Hamilton SR.
et al. Identification of ras oncogene mutations in
the stool of patients with curable colorectal tumors. Science.1992;256:102-105.
Traverso G, Shuber A, Levin B.
et al. Detection of APC mutations in fecal DNA from
patients with colorectal tumors. N Engl J Med.2002;346:311-320.
Ahlquist DA, Skoletsky JE, Boynton KA.
et al. Colorectal cancer screening by detection of altered human DNA in stool:
feasibility of a multitarget assay panel. Gastroenterology.2000;119:1219-1227.
Dong SM, Traverso G, Johnson C.
et al. Detecting colorectal cancer in stool with the use of multiple genetic
targets. J Natl Cancer Inst.2001;93:858-865.
Traverso G, Shuber A, Olsson L.
et al. Detection of proximal colorectal cancers through analysis of faecal